Sarcomatrix Therapeutics Corp
October 17, 2023
Franciscan B
Infectious Diseases
Sarcomatrix is a preclinical stage biopharma developing novel therapeutics and enabling technologies across multiple indications; starting with muscle wasting diseases and muscular dystrophies.
Company Type
Privately Funded
Website
http://www.sarcomatrix.com
CEO/Top Company Official
David Craig, MBA
Lead Product in Development
S-969 oral small molecule potent α7β1 integrin enhancer that promotes muscle regeneration in all muscle types by stimulating satellite cells.
Number Of Unlicensed Products
Two
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)